MedPath

Performance Evaluation Study

Conditions
Hematology
Interventions
Diagnostic Test: Fingerstick blood draw
Registration Number
NCT04618848
Lead Sponsor
Sight Diagnostics
Brief Summary

This study aims to establish OLO's performance accuracy of CBC results for finger prick samples across the OLO reportable range, and particularly around relevant medical decision points

Detailed Description

This study aims to establish OLO's performance accuracy of CBC results for finger prick samples across the OLO reportable range, and particularly around relevant medical decision points.

The evaluation will include two studies:

1. A matrix study will compare a capillary sample collected via finger prick with a venous sample collected into a blood tube, both scanned on OLO.

2. A method comparison study will compare Sight OLO to the site reference analyzer using a venous sample collected into a blood tube.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Blood samples will be collected from oncologic patients older than 18 years old arriving at the oncologic daily care center of Ichilov hospital, with predefined normal and abnormal blood counts
Exclusion Criteria
  • Patient younger than 18 years old
  • Visibly hemolyzed specimens (sample plasma should be checked for hemolysis by technician while selection of specimen from tube racks).
  • Visibly clotted specimens (Reasonable to assume that samples processed with clinical reported results are not clotted).
  • A sample that is not successfully scanned on OLO within 3 attempts (e.g. rejected due to irregular cell morphology, or microscopically visible hemolysis).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adult Oncology PatientsFingerstick blood drawAdult oncology patients
Primary Outcome Measures
NameTimeMethod
CBC ComparisonImmediately after sample collection is completed

Comparison between CBC results obtained from the Sight OLO and the reference device in venous and capillary samples covering medical decision points relevant to onclology patient

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath